Efficacy and safety of eliapixant in diabetic neuropathic pain and prediction of placebo responders with an exploratory novel algorithm: results from the randomized controlled phase 2a PUCCINI study
Science 387 , 329336 (2025)
In the debate over jardiance vs ozempic, patients and providers evaluate how these therapies differ in drug class, mechanism, and clinical use
doi: 10.1016/j.physbeh.2011.02.030 17 RoperSD
The complex biotechnological manufacturing of peptide-based therapies, which requires sophisticated facilities and lengthy production timelines, makes rapid scaling a logistical challenge
How GLP-1 Complements Lipedema Surgery While GLP-1 medications are not a cure for lipedema, they can be important in pre- and post-surgical care